Emergent BioSolutions | EBS - Action

Prix De L'Action
7.93
Variation Quotidienne
-0.15 -1.86%
Mensuellement
-11.79%
Annuel
70.17%
Q1 Prévisions
7.84




Action Changement Date
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Akebia Therapeutics USD 15.61M 3.03M 2025-12
ALKERMES USD 196.62M 5.63M 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amarin USD 184.7M 13.46M 2025-09
ANI Pharmaceuticals USD 143.07M 3.41M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Coherus Biosciences USD 3.17M 1.12M 2025-12
Emergent BioSolutions USD 328.9M 25.2M 2023-12
Exelixis USD 27.4M 3.92M 2025-09
Glaxosmithkline GBP 6.12B 46M 2025-09
Heron Therapeutics USD 54.57M 2.33M 2022-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Lexicon Pharmaceuticals USD 168K 33K 2025-06
Lonza CHF 1.68B 163M 2025-12
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Myriad Genetics USD 30.6M 1000K 2025-12
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 69M 300K 2025-12
Pacira USD 152.86M 4.82M 2025-12
Pfizer USD 11.47B 201M 2025-09
PTC Therapeutics USD 79.65M 26.96M 2025-12
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
United Therapeutics USD 183.1M 6.6M 2025-12
Vanda Pharmaceuticals USD 1.85M 190K 2025-12